Patents by Inventor Mongkol Sriwongjanya

Mongkol Sriwongjanya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240130972
    Abstract: The present Invention relates to a pellet comprising melatonin and methods of treating insomnia.
    Type: Application
    Filed: February 24, 2022
    Publication date: April 25, 2024
    Inventors: Mongkol SRIWONGJANYA, Lin Yu LIANG, Paul GOLDSMITH, Bruce CAMPBELL
  • Patent number: 11833133
    Abstract: A solid oral pharmaceutical composition is disclosed, which comprises: a first active ingredient, which is pitavastatin or a pharmaceutically acceptable salt thereof; a second active ingredient, which is ezetimibe or a pharmaceutically acceptable salt thereof; and at least one excipient, including a diluent, a stabilizing agent, a disintegrant, a binding agent, a sweetener, a lubricant, a glidant, a flavor, a coloring agent or a combination thereof.
    Type: Grant
    Filed: August 5, 2021
    Date of Patent: December 5, 2023
    Assignee: ORIENT PHARMA CO., LTD.
    Inventors: Chien-Yu Chen, David Wong, Mongkol Sriwongjanya
  • Publication number: 20220047547
    Abstract: A solid oral pharmaceutical composition is disclosed, which comprises: a first active ingredient, which is pitavastatin or a pharmaceutically acceptable salt thereof; a second active ingredient, which is ezetimibe or a pharmaceutically acceptable salt thereof; and at least one excipient, including a diluent, a stabilizing agent, a disintegrant, a binding agent, a sweetener, a lubricant, a glidant, a flavor, a coloring agent or a combination thereof.
    Type: Application
    Filed: August 5, 2021
    Publication date: February 17, 2022
    Inventors: Chien-Yu CHEN, David WONG, Mongkol SRIWONGJANYA
  • Patent number: 8092831
    Abstract: The present invention relates to an oral pharmaceutical formulation that employs: (1) a compressed core containing a decongestant or pharmaceutically acceptable salt thereof; (2) a delayed release coating on the compressed core and (3) immediate release therapeutic amounts of a decongestant and an antihistamine.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: January 10, 2012
    Assignee: Andrx Pharmaceuticals, LLC
    Inventors: Unchalee Kositprapa, Mongkol Sriwongjanya
  • Publication number: 20100323010
    Abstract: The present invention relates to a controlled release pellet of metoprolol and its pharmaceutically acceptable salts that uses a water soluble or a water swellable inert starting seed or core.
    Type: Application
    Filed: August 10, 2010
    Publication date: December 23, 2010
    Applicant: ANDRX PHARMACEUTICALS, LLC
    Inventors: Mongkol Sriwongjanya, Samuel Yuk, Avinash Nangia
  • Patent number: 7790200
    Abstract: The present invention relates to a controlled release pellet of metoprolol and its pharmaceutically acceptable salts that uses a water soluble or a water swellable inert starting seed or core.
    Type: Grant
    Filed: October 19, 2007
    Date of Patent: September 7, 2010
    Assignee: Andrx Pharmaceuticals, LLC
    Inventors: Mongkol Sriwongjanya, Samuel Yuk, Avinash Nangia
  • Publication number: 20080044467
    Abstract: The present invention relates to a controlled release pellet of metoprolol and its pharmaceutically acceptable salts that uses a water soluble or a water swellable inert starting seed or core.
    Type: Application
    Filed: October 19, 2007
    Publication date: February 21, 2008
    Inventors: Mongkol Sriwongjanya, Samuel Yuk, Avinash Nangia
  • Patent number: 7314640
    Abstract: The present invention relates to a controlled release pellet of metoprolol and its pharmaceutically acceptable salts that uses a water soluble or a water swellable inert starting seed or core.
    Type: Grant
    Filed: July 11, 2003
    Date of Patent: January 1, 2008
    Inventors: Mongkol Sriwongjanya, Samuel Yuk, Avinash Nangia
  • Publication number: 20070286902
    Abstract: In certain embodiments the invention is directed to an oral solid pharmaceutical dosage form comprising: a first portion of a short acting sedative-hypnotic in an release immediate release component; and a second portion of the sedative-hypnotic in a delayed component, the delayed release component comprising (i) a unitary core comprising the second portion of sedative-hypnotic dispersed in a controlled release matrix and (ii) a delayed release coating surrounding the core.
    Type: Application
    Filed: June 7, 2006
    Publication date: December 13, 2007
    Applicant: ABRIKA Pharmaceuticals
    Inventors: Jianbo Xie, Timothy Weng, Mongkol Sriwongjanya
  • Publication number: 20070232697
    Abstract: Disclosed is a process for preparing a free base composition of a pharmaceutical compound comprising combining an acid addition salt of a pharmaceutical compound, at least one solvent and a sufficient amount of at least one base to convert the acid addition salt of the pharmaceutical to a free base of the pharmaceutical, to form a free base composition of the pharmaceutical compound.
    Type: Application
    Filed: March 29, 2006
    Publication date: October 4, 2007
    Applicant: Andrx Labs LLC
    Inventors: Jianbo Xie, David Barman, Mongkol Sriwongjanya, Sam Yuk
  • Patent number: 6994871
    Abstract: A controlled release pharmaceutical formulation for the administration of an antihistamine and decongestant to a patient wherein the formulation employs a compressed matrix core for the controlled release of a decongestant and an immediate release coating for the immediate release of the antihistamine.
    Type: Grant
    Filed: September 16, 2002
    Date of Patent: February 7, 2006
    Assignee: Andrx Pharmaceuticals, Inc.
    Inventors: Mongkol Sriwongjanya, Timothy Weng, David Barman, Unchalee Kositprapa
  • Publication number: 20040091533
    Abstract: The present invention relates to an oral pharmaceutical formulation that employs: (1) a compressed core containing a decongestant or pharmaceutically acceptable salt thereof; (2) a delayed release coating on the compressed core and (3) immediate release therapeutic amounts of a decongestant and an antihistamine.
    Type: Application
    Filed: November 8, 2002
    Publication date: May 13, 2004
    Inventors: Unchalee Kositprapa, Mongkol Sriwongjanya
  • Publication number: 20030049319
    Abstract: A controlled release pharmaceutical formulation for the administration of an antihistamine and decongestant to a patient wherein the formulation employs a compressed matrix core for the controlled release of a decongestant and an immediate release coating for the immediate release of the antihistamine.
    Type: Application
    Filed: September 16, 2002
    Publication date: March 13, 2003
    Inventors: Mongkol Sriwongjanya, Timothy Weng, David Barman, Unchalee Kositprapa
  • Patent number: 6156342
    Abstract: A controlled release dosage form for an analgesic that does not contain an expanding polymer and comprising a core containing the analgesic, preferably tramadol or it pharmaceutically acceptable deviates and a semipermeable membrane coating the core.
    Type: Grant
    Filed: May 26, 1998
    Date of Patent: December 5, 2000
    Assignee: Andex Pharmaceuticals, Inc.
    Inventors: Mongkol Sriwongjanya, Timothy Weng, Joseph Chou, Chih-Ming Chen